Rona Therapeutics is based in Shanghai, China. It has raised $200M in total funding. Latest round: Series A+.
Rona Therapeutics is based in Shanghai, China. Rona Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A+ announced in July 2024. The round record for Rona Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include LongRiver Investments, Lilly Asia Ventures, BioTrack Capital, Zhongqi Capital, Zhaode Investment, CMB International and 3 others. 9 distinct backers are named across the disclosed rounds.
Round data for Rona Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026